The results showed that divergent tumor weights between 0.08 and 0.63 g did not influence blood 89Zr-CD25 IgG level at day five (Spearman’s r = -0.4235, P = 0.103; Figure 3A). This evidence concerns the gene IL2RA and neoplasm.